Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$130.29
-1.8%
$126.57
$99.71
$141.23
$225.97B0.695.56 million shs6.77 million shs
Dover Co. stock logo
DOV
Dover
$181.83
+0.6%
$195.43
$168.20
$222.31
$24.95B1.24892,900 shs1.28 million shs
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
$139.88
-2.9%
$133.14
$123.02
$150.45
$46.40B0.362.05 million shs2.10 million shs
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
-1.72%-5.37%-0.81%+14.42%+7.89%
Dover Co. stock logo
DOV
Dover
+0.46%-4.26%-10.74%-9.70%+3.74%
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
-2.87%-1.35%+6.42%+6.87%+10.39%
Remove Ads
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Abbott Laboratories stock logo
ABT
Abbott Laboratories
4.8537 of 5 stars
2.43.04.24.53.52.52.5
Dover Co. stock logo
DOV
Dover
4.6925 of 5 stars
3.33.04.22.11.91.72.5
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
4.5782 of 5 stars
2.15.04.22.53.52.51.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Abbott Laboratories stock logo
ABT
Abbott Laboratories
2.84
Moderate Buy$137.945.87% Upside
Dover Co. stock logo
DOV
Dover
2.64
Moderate Buy$218.9120.39% Upside
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
2.20
Hold$143.642.69% Upside

Current Analyst Ratings Breakdown

Latest KMB, DOV, and ABT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/10/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$133.00 ➝ $150.00
3/4/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$135.00 ➝ $160.00
3/4/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$138.00 ➝ $154.00
1/31/2025
Dover Co. stock logo
DOV
Dover
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$217.00 ➝ $211.00
1/31/2025
Dover Co. stock logo
DOV
Dover
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$220.00 ➝ $225.00
1/31/2025
Dover Co. stock logo
DOV
Dover
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$208.00 ➝ $230.00
1/31/2025
Dover Co. stock logo
DOV
Dover
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSector Perform ➝ Sector Perform$196.00 ➝ $214.00
1/31/2025
Dover Co. stock logo
DOV
Dover
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$200.00 ➝ $215.00
1/31/2025
Dover Co. stock logo
DOV
Dover
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$205.00 ➝ $213.00
1/29/2025
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$132.00 ➝ $134.00
1/29/2025
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$161.00 ➝ $158.00
(Data available from 3/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$41.95B5.39$5.61 per share23.22$22.36 per share5.83
Dover Co. stock logo
DOV
Dover
$7.75B3.22$9.55 per share19.03$50.68 per share3.59
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
$20.06B2.31$9.78 per share14.30$2.94 per share47.58
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$13.40B$7.6517.0322.742.5231.95%20.74%11.19%4/16/2025 (Estimated)
Dover Co. stock logo
DOV
Dover
$2.70B$19.459.3517.672.0632.95%21.03%10.22%4/24/2025 (Estimated)
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
$2.55B$7.5518.5317.754.4612.69%201.43%14.45%4/22/2025 (Estimated)

Latest KMB, DOV, and ABT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
1/30/2025Q4 2024
Dover Co. stock logo
DOV
Dover
$2.20$2.20N/A$10.38$1.95 billionN/A
1/28/2025Q4 2024
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
$1.50$1.50N/A$1.34$4.87 billionN/A
1/22/2025Q4 2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.34$1.34N/A$5.27$11.03 billion$10.97 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$2.361.81%+7.17%30.85%54 Years
Dover Co. stock logo
DOV
Dover
$2.061.13%+1.00%10.59%70 Years
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
$5.043.60%+2.29%66.75%54 Years

Latest KMB, DOV, and ABT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/21/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
quarterly$0.591.75%4/15/20254/15/20255/15/2025
1/28/2025
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
quarterly$1.263.84%3/7/20253/7/20254/2/2025
2/13/2025
Dover Co. stock logo
DOV
Dover
quarterly$0.51501.02%2/28/20252/28/20253/14/2025
12/13/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
quarterly$0.592.08%1/15/20251/15/20252/14/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.32
1.60
1.14
Dover Co. stock logo
DOV
Dover
0.36
2.04
1.52
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
7.05
0.80
0.54

Institutional Ownership

CompanyInstitutional Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
75.18%
Dover Co. stock logo
DOV
Dover
84.46%
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
76.29%

Insider Ownership

CompanyInsider Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.47%
Dover Co. stock logo
DOV
Dover
1.30%
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
0.62%
CompanyEmployeesShares OutstandingFree FloatOptionable
Abbott Laboratories stock logo
ABT
Abbott Laboratories
114,0001.73 billion1.73 billionOptionable
Dover Co. stock logo
DOV
Dover
25,000137.23 million135.44 millionOptionable
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
44,000331.69 million329.63 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Abbott Laboratories stock logo

Abbott Laboratories NYSE:ABT

$130.29 -2.37 (-1.79%)
Closing price 03/12/2025 03:59 PM Eastern
Extended Trading
$130.07 -0.22 (-0.17%)
As of 03/12/2025 07:25 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Dover stock logo

Dover NYSE:DOV

$181.83 +1.06 (+0.59%)
Closing price 03/12/2025 03:59 PM Eastern
Extended Trading
$182.00 +0.17 (+0.09%)
As of 03/12/2025 07:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Dover Corporation provides equipment and components, consumable supplies, aftermarket parts, software and digital solutions, and support services worldwide. The company's Engineered Products segment provides various equipment, component, software, solution, and services that are used in vehicle aftermarket, waste handling, industrial automation, aerospace and defense, industrial winch and hoist, and fluid dispensing end-market. This segment offers manual and power clamp, rotary and linear mechanical indexer, conveyor, pick and place unit, glove port, and manipulator, as well as end-of-arm robotic gripper, slide, and end effector; winches, hoists, bearings, drives, and electric monitoring system; and radio frequency and microwave filters and switches, and signal intelligence solutions. Its Clean Energy & Fueling segment offers component, equipment, and software and service solution enabling safe storage and transport of fuel, cryogenic gases, and hazardous fluids, as well as operation of retail fueling and vehicle wash establishment. The company's Imaging & Identification segment provides precision marking and coding, product traceability equipment, brand protection, and digital textile printing equipment and solution, as well as related consumable, software, and service to packaged and consumer goods, pharmaceutical, manufacturing, fashion and apparel, and other end-market. Its Pumps & Process Solutions segment manufactures specialty pump, connector, flow meter, fluid connecting solution, plastics and polymer processing equipment, and engineered components for rotating and reciprocating machines. The company's Climate & Sustainability Technologies segment manufactures refrigeration system, refrigeration display case, commercial glass refrigerator and freezer door, and brazed plate heat exchanger for industrial heating and cooling, and residential climate control applications. The company was incorporated in 1947 and is headquartered in Downers Grove, Illinois.

Kimberly-Clark stock logo

Kimberly-Clark NYSE:KMB

$139.88 -4.21 (-2.92%)
Closing price 03/12/2025 03:58 PM Eastern
Extended Trading
$139.89 +0.01 (+0.01%)
As of 03/12/2025 07:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company's Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names. Its Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The company's K-C Professional segment offers wipers, tissues, towels, apparel, personal protective equipment, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and KleenGuard brands. It also sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce; and away-from-home use products directly to distributors, manufacturing, lodging, office building, food service, and public facilities, as well as through e-commerce. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.